miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer (Q34288764)

1 August 2017

title

miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer (English)

1 reference

1 August 2017

1 reference

Zhiwei Zhong

1

1 reference

1 August 2017

Zhuo Dong

series ordinal

2

1 reference

1 August 2017

Lihua Yang

series ordinal

3

1 reference

1 August 2017

Zhaohui Gong

series ordinal

4

1 reference

1 August 2017

publication date

18 July 2012

1 reference

Journal of Cancer Research and Clinical Oncology

1 August 2017

published in

1 reference

1 August 2017

volume

138

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1781-1788

1 reference

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

DNA mismatch repair: molecular mechanism, cancer, and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Structure and function of the components of the human DNA mismatch repair system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Mechanisms and functions of DNA mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Lung cancer: New biological insights and recent therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

Modulation of mismatch repair and genomic stability by miR-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1287-Y

The widespread regulation of microRNA biogenesis, function and decay

21 January 2018

1 reference

12 December 2020

Expression of DNA mismatch repair gene MSH2 in cytological material from lung cancer patients

1 reference

12 December 2020

hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas

1 reference

12 December 2020

Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance

1 reference

12 December 2020

10.1007/S00432-012-1287-Y

Identifiers

DOI

1 reference

1 August 2017

1 reference